Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
corporate governance
Pharma
Alexis Borisy sheds 2 board jobs to stay with Blueprint
Blueprint installed a director resignation policy after Alexis Borisy's reelection last year without a majority shareholder vote sparked concerns.
Angus Liu
Apr 30, 2024 7:20am
Alexis Borisy loses majority investor support at Blueprint
Jun 28, 2023 11:16am
AstraZeneca charts major upgrade to its Forest restoration aims
Jun 28, 2023 10:25am
AZ's China head refutes news report about potential spinoff
Jun 20, 2023 10:20am
Doctors see pharma reputation as top priority for Rx decisions
Mar 2, 2023 7:30am
Sanofi unveils new corporate brand—and it goes for Genzyme, too
Feb 3, 2022 11:37am
